Idera Pharmaceuticals reported $39.18M in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Aceto ACET:US 257.2M 11.58M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Amgen AMGN:US $ 64993M 5220M
Biogen BIIB:US $ 23806.7M 663.7M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Cytrx CYTR:US 17.04M 7.74M
Dynavax Technologies DVAX:US $ 919.71M 271.8M
Eli Lilly And LLY:US $ 48187M 378M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Idera Pharmaceuticals IDRA:US $ 39.18M 5.23M
Mirati Therapeutics MRTX:US $ 1253.43M 102.27M
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
Seattle Genetics SGEN:US $ 3977.88M 25.72M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M